GUARD-AF was a randomized prospective trial to assess whether screening for atrial fibrillation (AF) using a 14-day continuous electrocardiographic (ECG) monitor in people ≥70 years seen in primary ...

Zhang Y, Yu S, Chen Z, et al. In Mendelian randomization analyses, genetic predisposition to GDM was associated with increased risk of coronary artery disease (odds ratio, 1.09 [95% confidence ...

Rasmussen LD, Schmidt SE, Knuuti J, et al. There were 13,748 individuals included in this pooled study, and the primary endpoint was observed in 2.3% (n = 313) of patients. Very-low, low, and moderate ...

Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode three of four, Ms. Amy Brownell will interview Ms. Corrin McCloskey and Dr. Joseph Goeke on developing a ...

The following are key points to remember from a state-of-the-art review on multimodality imaging in the diagnostic work-up of patients with cardiac masses: ...

This observational study reports that transseptal MViV with SAPIEN 3/SAPIEN 3 Ultra was associated with excellent procedural outcomes, low complication rates, significant improvement in valve ...

Women with hypertensive disorders of pregnancy (HDP) have greater odds of having ACS in the future. Furthermore, pregnancy with HDP significantly increased the risk of a higher SYNTAX score, a marker ...

In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...

The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...

Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...

In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...